Cancer is associated with inferior outcome in patients with ischemic stroke

Abstract

Whether patients with stroke and cancer exhibit specific characteristics has remained controversial. Medical records of patients with ischemic stroke in 2014 or 2015 registered in the Swiss Stroke Registry of Zurich were retrospectively analyzed and integrated with regional cancer registry data. Associations of clinical and outcome parameters with cancer diagnosed up to 5 years prior to stroke were tested. Of 753 patients with ischemic stroke, 59 patients with cancer were identified. History of venous thromboembolism (p\u2009<\u20090.001) was associated with cancer while age and cardiovascular risk factors were not. Higher levels of D-dimers (p\u2009=\u20090.001), erythrocyte sedimentation rate (p\u2009=\u20090.003), C-reactive protein (CRP) (p\u2009<\u20090.001), and lower levels of hemoglobin (p\u2009=\u20090.003) were associated with cancer. For platelets, pathologically low (p\u2009=\u20090.034) or high levels (p\u2009<\u20090.001) were linked to cancer. Modified Rankin scale (mRS) scores\u2009≥\u20094 on admission and at follow-up were more frequent in cancer patients (p\u2009=\u20090.038 and p\u2009=\u20090.001). Poor post-stroke survival was associated with cancer (HR 2.2, p\u2009<\u20090.001). Multivariable analysis identified venous thromboembolism (OR 5.1), pathologic platelet count (OR\u2009=\u20092.9), low hemoglobin (OR 2.5) and elevated CRP (OR 1.8) as independently associated with cancer. In multivariable Cox regression, risk for death was associated with cancer (HR 1.7), low hemoglobin (HR 2.6), mRS on admission\u2009≥\u20094 (HR 1.9), pathologic platelet count (HR 1.6), female sex (HR 1.7), and elevated CRP (HR 1.4). Considering cancer as a cofactor for post-stroke outcome may impact clinical decision making.